SCHEMBL8459010

SCHEMBL8459010

CCCCCCCOc1cc2ccc(OC(=O)c3ccccc3)cc2cc1C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.43
NFKB1 P19838 3/20 0.43
NFKB2 Q00653 3/20 0.43
RELA Q04206 3/20 0.43
NPC1 O15118 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CNR2 P34972 2/20 0.43
FAAH O00519 1/20 0.43
CNR1 P21554 1/20 0.43
MAPT P10636 4/20 0.43
POLB P06746 1/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
RARA P10276 2/20 0.43
RARB P10826 2/20 0.43
RARG P13631 2/20 0.43
NR1I2 O75469 1/20 0.43
PGR P06401 1/20 0.43
HSPD1 P10809 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8458238 0.92 KMT2A (0.44) LMNASMN1; SMN2MAPTPOLBMEN1
SCHEMBL8459004 0.91 MEN1 (0.43) LMNASMN1; SMN2MAPTMEN1KMT2A
SCHEMBL8459777 0.90 MEN1 (0.44) LMNASMN1; SMN2MAPTMEN1KMT2A
SCHEMBL8455746 0.90 ALOX5AP (0.43) LMNAMAPTMEN1KMT2ATDP1
SCHEMBL8457496 0.89 KMT2A (0.41) LMNASMN1; SMN2CNR2MAPTPOLB
SCHEMBL8457981 0.89 ALOX5AP (0.44) LMNAMAPTMEN1KMT2ATDP1
SCHEMBL8457462 0.85 HIF1A (0.47) LMNACNR2FAAHCNR1MAPT
SCHEMBL8457121 0.84 RARA (0.53) LMNAMAPTMEN1KMT2ATDP1
SCHEMBL7920651 0.81 RARB (0.54) LMNASMN1; SMN2CNR2FAAHCNR1
SCHEMBL7521122 0.81 MEN1 (0.61) LMNASMN1; SMN2MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5952382-A INHIBITING THE BIOLOGICAL EFFECTS OF AN OVERREGULATION OF RETINOID ACID RECEPTORS AND/OR OF A HYPERVITAMINOSIS A; TREATING SKIN DISORDER, EYE VISION DEFECTS, SKIN AGING CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1999-09-14 US disclosed